Cargando…
Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery
Inhalation administration, compared with intravenous administration, significantly enhances chemotherapeutic drug exposure to the lung tissue and may increase the therapeutic effect for pulmonary anticancer. However, further identification of cancer cells after lung deposition of inhaled drugs is ne...
Autores principales: | Chen, Rui, Xu, Liu, Fan, Qin, Li, Man, Wang, Jingjing, Wu, Li, Li, Weidong, Duan, Jinao, Chen, Zhipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241141/ https://www.ncbi.nlm.nih.gov/pubmed/28844172 http://dx.doi.org/10.1080/10717544.2017.1365395 |
Ejemplares similares
-
Validation and Application of an Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry Method for Yuanhuacine Determination in Rat Plasma after Pulmonary Administration: Pharmacokinetic Evaluation of a New Drug Delivery System
por: Li, Man, et al.
Publicado: (2016) -
Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration
por: Abdelbary, Aly A, et al.
Publicado: (2015) -
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020) -
Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices
por: Cosa, Nathan, et al.
Publicado: (2016) -
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
por: Leong, Ellenmae W. X., et al.
Publicado: (2022)